Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, featuring promising progress throughout various medical and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, extra reputable choice for therapeutic use, specially